 Antierythrocyte autoantibody formation therapy gamma-interferon cardiovascular renal pulmonary dermatologic toxicities gamma-interferon IFN autoimmune toxicities authors development warm autoantibodies erythrocytes patient cetus intravenous bolus times week gamma-IFN times week metastatic renal cell carcinoma Other potential causes autoantibody formation drugs infection collagen vascular disease gamma-IFN potential autoimmunity due aberrant expression restricted antigens inhibition normal cellular immune suppressor mechanisms